Peymane Adab

Peymane Adab

Auto-generated profile, based on publicly available information

Peymane Adab

Institute of Applied Health Research, University of Birmingham, Birmingham, UK

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2020 in BMJ
Verified
Journal Article
Closed access
PDF file
RJRachel Jordan
Rachel Jordan
PAPeymane Adab
Peymane Adab
KCK K Cheng
K K Cheng
A long list is emerging from largely unadjusted analyses, with age near the top

3 November 2011 in BMJ
Verified
Journal Article
Open access
PDF file
KJKate Jolly
Kate Jolly
ALAmanda Lewis
Amanda Lewis
JBJane Beach
Jane Beach
JDJohn Denley
John Denley
PAPeymane Adab
Peymane Adab
PAPaul Aveyard
Paul Aveyard
Objective To assess the effectiveness of a range of weight management programmes in terms of weight loss.Design Eight arm randomised controlled trial.Setting Primary care trust in Birmingham, England.Participants 740 obese or overweight men and women with a comorbid disorder identified from general practice records.Interventions Weight loss programmes of 12 weeks’ duration: Weight Watchers; Slimming World; Rosemary Conley; group based, dietetics led programme; general practice one to one counselling; pharmacy led one to one counselling; choice of any of the six programmes. The comparator group was provided with 12 vouchers enabling free entrance to a local leisure (fitness) centre.Main outcome measures The primary outcome was weight loss at programme end (12 weeks). Secondary outcomes were weight loss at one year, self reported physical activity, and percentage weight loss at programme end and one year.Results Follow-up data were available for 658 (88.9%) participants at programme end and 522 (70.5%) at one year. All programmes achieved significant weight loss from baseline to programme end (range 1.37 kg (general practice) to 4.43 kg (Weight Watchers)), and all except general practice and pharmacy provision resulted in significant weight loss at one year. At one year, only the Weight Watchers group had significantly greater weight loss than did the comparator group (2.5 (95% confidence interval 0.8 to 4.2) kg greater loss,). The commercial programmes achieved significantly greater weight loss than did the primary care programmes at programme end (mean difference 2.3 (1.3 to 3.4) kg). The primary care programmes were the most costly to provide. Participants allocated to the choice arm did not have better outcomes than those randomly allocated to a programme.Conclusions Commercially provided weight management services are more effective and cheaper than primary care based services led by specially trained staff, which are ineffective.Trial registration Current Controlled Trials ISRCTN25072883.

1 November 2016 in The Lancet
Verified
Journal Article
Open access
PAPaul Aveyard
Paul Aveyard
ALAmanda Lewis
Amanda Lewis
STSarah Tearne
Sarah Tearne
KHKathryn Hood
Kathryn Hood
ACAnna Christian-Brown
Anna Christian-Brown
SJSusan A Jebb
Susan A Jebb
Obesity is a common cause of non-communicable disease. Guidelines recommend that physicians screen and offer brief advice to motivate weight loss through referral to behavioural weight loss programmes. However, physicians rarely intervene and no trials have been done on the subject. We did this trial to establish whether physician brief intervention is acceptable and effective for reducing bodyweight in patients with obesity. In this parallel, two-arm, randomised trial, patients who consulted 137 primary care physicians in England were screened for obesity. Individuals could be enrolled if they were aged at least 18 years, had a body-mass index of at least 30 kg/m2 (or at least 25 kg/m2 if of Asian ethnicity), and had a raised body fat percentage. At the end of the consultation, the physician randomly assigned participants (1:1) to one of two 30 s interventions. Randomisation was done via preprepared randomisation cards labelled with a code representing the allocation, which were placed in opaque sealed envelopes and given to physicians to open at the time of treatment assignment. In the active intervention, the physician offered referral to a weight management group (12 sessions of 1 h each, once per week) and, if the referral was accepted, the physician ensured the patient made an appointment and offered follow-up. In the control intervention, the physician advised the patient that their health would benefit from weight loss. The primary outcome was weight change at 12 months in the intention-to-treat population, which was assessed blinded to treatment allocation. We also assessed asked patients' about their feelings on discussing their weight when they have visited their general practitioner for other reasons. Given the nature of the intervention, we did not anticipate any adverse events in the usual sense, so safety outcomes were not assessed. This trial is registered with the ISRCTN Registry, number ISRCTN26563137. Between June 4, 2013, and Dec 23, 2014, we screened 8403 patients, of whom 2728 (32%) were obese. Of these obese patients, 2256 (83%) agreed to participate and 1882 were eligible, enrolled, and included in the intention-to-treat analysis, with 940 individuals in the support group and 942 individuals in the advice group. 722 (77%) individuals assigned to the support intervention agreed to attend the weight management group and 379 (40%) of these individuals attended, compared with 82 (9%) participants who were allocated the advice intervention. In the entire study population, mean weight change at 12 months was 2·43 kg with the support intervention and 1·04 kg with the advice intervention, giving an adjusted difference of 1·43 kg (95% CI 0·89-1·97). The reactions of the patients to the general practitioners' brief interventions did not differ significantly between the study groups in terms of appropriateness (adjusted odds ratio 0·89, 95% CI 0·75-1·07, p=0·21) or helpfulness (1·05, 0·89-1·26, p=0·54); overall, four (<1%) patients thought their intervention was inappropriate and unhelpful and 1530 (81%) patients thought it was appropriate and helpful. A behaviourally-informed, very brief, physician-delivered opportunistic intervention is acceptable to patients and an effective way to reduce population mean weight. The UK National Prevention Research Initiative.

29 March 2018 in BMJ
Verified
Journal Article
Closed access
PDF file
PAPeymane Adab
Peymane Adab
MPMiranda Pallan
Miranda Pallan
PWPeter H Whincup
Peter H Whincup
It works for most people most of the time

1 September 2007 in The Lancet
Verified
Journal Article
Closed access
PYP Yin
P Yin
CJCq Jiang
Cq Jiang
KCKk Cheng
Kk Cheng
TLTai-Hing Lam
Tai-Hing Lam
KLKh Lam
Kh Lam
PAP Adab
P Adab

14 July 2006 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
CJChaoqiang Jiang
Chaoqiang Jiang
GTG.Neil Thomas
G.Neil Thomas
TLTai-Hing Lam
Tai-Hing Lam
CSCatherine Mary Schooling
Catherine Mary Schooling
WZWeisen Zhang
Weisen Zhang
KCK.K. Cheng
K.K. Cheng
The Guangzhou Biobank Cohort Study (GBCS), initiated by TH Lam (Hong Kong), CQ Jiang (Guangzhou), and KK Cheng (Birmingham), has been in part modelled on the Kadoorie Study of Chronic Disease in China (KSCDC)1 and the UK Biobank.2 Initial seed funding came from the Universities of Hong Kong and Birmingham, the Guangzhou No. 12 Hospital (Guangzhou Occupational Disease Prevention & Treatment Centre), the Guangzhou Public Health Bureau, and the Guangzhou Science and Technology Bureau. The Clinical Trials Service Unit at Oxford University has provided technical advice, especially in the planning and setting up of the project.